Delivery Order SPE2DB22D3301-SPE2DB25FZ1EP
- Not listed
- The Defense Logistics Agency awarded a $1,842.03 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Potassium Phosphate 45 mmol/15 ml pharmaceutical product. This firm fixed price, non-set-aside contract is scheduled for completion by September 4, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds a significant indefinite...
- The Defense Logistics Agency awarded a $5,932.16 firm fixed-price delivery order to AmerisourceBergen Drug Corp on March 14, 2025, for the supply of Potassium Phosphate 45 mmol/15 ml in 15 ml units, with performance completion targeted for March 17, 2025. This non-set-aside competitive award is performed at the vendor's corporate office location in Conshohocken, Pennsylvania, and represents a child delivery order under AmerisourceBergen's larger contract vehicle with the DLA. AmerisourceBergen...
- The Defense Logistics Agency awarded a $1,385.30 delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Potassium Phosphate 15 mmol/5 ml in 5 ml vials. This firm fixed-price contract, with an ultimate completion date of August 15, 2025, will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The award was not set aside and represents a competitive procurement action under the company's existing contract vehicle with the agency. This delivery order...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of potassium chloride, a critical pharmaceutical commodity. This firm fixed-price delivery order, valued at $2,602.87, is scheduled for completion by October 1, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Potassium Chloride Extended Release 10 MEQ tablets in quantities of 100 with a ceiling value of $1,167.36. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement and is scheduled for completion by September 17, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Potassium Chloride Extended Release 10 milliequivalent tablets in quantities of 1,000 units, with a ceiling value of $1,326.38. This is a firm fixed-price delivery order with an ultimate completion date of July 15, 2025, and represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Potassium Chloride ER 20 MEQ tablets (100-count packages) with a ceiling value of $13,579.18. This contract, awarded on September 18, 2025, represents a firm fixed-price delivery order with an ultimate completion date of September 19, 2025, and carries no set-aside designation. The work is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Potassium Chloride Extended Release 8 MEQ tablets in quantities of 500 units, with a contract ceiling value of $7,195.15. This is a firm fixed-price delivery order with an ultimate completion date of July 25, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Potassium Chloride Extended Release 10 MEQ tablets in quantities of 1,000 units. This contract, valued at $22,252.80 with firm fixed pricing, is scheduled for completion by September 19, 2025, and represents a non-set-aside, competitively awarded procurement. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Potassium Chloride 10 mEq/100 mL solution in 100 mL units, with a contract ceiling value of $1,311.00. The award was made on August 26, 2025, with an ultimate completion date of August 27, 2025, under a firm fixed-price delivery order arrangement with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FZ1EPDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $7,184.64 to AmerisourceBergen Drug Corp for the supply of Potassium Phosphate 45 mmol/15 ml in 15 ml units. This is a firm fixed price delivery order with an ultimate completion date of September 19, 2025, and no set-aside designation was used in the award. The vendor will perform the work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's DLA IDC enables it to supply a broad range of pharmaceutical products and medical supplies to support Defense Health Agency operations and other government healthcare systems globally. This specific delivery order represents one of numerous competitively awarded transactions fulfilling federal medical supply requirements across multiple therapeutic domains, demonstrating the contractor's capability to meet diverse pharmaceutical procurement needs for the Defense Department.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.2k | 9/18/25 |